Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

The OVATION 3 Study Initiates First Trial Site for Ovarian Cancer

May 8th 2025, 7:00pm

Article

The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly diagnosed advanced ovarian cancer.

Nurse’s Big Personality Makes Cancer Treatment More Bearable.

May 6th 2025, 5:00pm

Article

She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients smiled. The other nurses smiled.

First Patient Dosed With Azenosertib in Cyclin E1+ Ovarian Cancer

May 2nd 2025, 4:00pm

Article

The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 DENALI clinical trial.

FDA Fast Tracks INX-315 for Tough-to-Treat Ovarian Cancer

April 29th 2025, 3:00pm

Article

INX-315, a CDK2 inhibitor, received FDA fast track designation for patients with CCNE1-amplified platinum-resistant ovarian cancer.

Breaking Down The Use of Rina-S in Advanced Ovarian Cancer

April 16th 2025, 8:00pm

Video

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

BELLA Clinical Trial Initiated in Platinum-Resistant Ovarian Cancer

April 7th 2025, 3:00pm

Article

The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.

Development of Nemvaleukin for Platinum-Resistant Ovarian Cancer Halted

April 3rd 2025, 1:00pm

Article

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on to final analysis.

Relacorilant Plus Chemo Meets Primary Goal in Ovarian Cancer Trial

March 31st 2025, 3:29pm

Article

The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ovarian cancer.

Rina-S Generates Antitumor Activity in Heavily Pretreated Ovarian Cancer

March 27th 2025, 1:00pm

Video

Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the phase 2 RAINFOL-01 study.

First Patient Dosed in Phase 3 Trial of IBI354 for Ovarian Cancer

March 24th 2025, 7:00pm

Article

The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.